• Login
    View Item 
    •   Home
    • Hospital Research
    • Munster
    • Cork University Hospital
    • View Item
    •   Home
    • Hospital Research
    • Munster
    • Cork University Hospital
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Map of Submissions

    Home Page
    UlsterN
    4963
    UlsterS
    4963
    Connacht
    1639
    Munster
    58
    Leinster
    457

    Browse

    All of Lenus, The Irish Health RepositoryCommunitiesTitleAuthorsDate publishedSubjectsThis CollectionTitleAuthorsDate publishedSubjects

    My Account

    LoginRegister

    About

    About LenusDirectory of Open Access JournalsOpen Access Publishing GuideNational Health Library & Knowledge ServiceGuide to Publishers' PoliciesFAQsTerms and ConditionsVision StatementORCID Unique identifiers for ResearchersHSE position statement on Open AccessNational Open Research Forum (NORF)Zenodo (European Open Research repository)

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Authors
    Langabeer, Stephen E
    Crampe, Mireille
    Haslam, Karl
    Kelly, Johanna
    Cahill, Mary R
    Issue Date
    2010-07
    MeSH
    Antineoplastic Agents
    Drug Resistance, Neoplasm
    Female
    Fusion Proteins, bcr-abl
    Humans
    Incidental Findings
    Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    Middle Aged
    Piperazines
    Protein Kinase Inhibitors
    Pyrimidines
    RNA, Messenger
    RNA, Neoplasm
    Remission Induction
    Tumor Markers, Biological
    Show allShow less
    
    Metadata
    Show full item record
    Citation
    Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. 2010, 34 (7):e176-7 Leuk. Res.
    Journal
    Leukemia research
    URI
    http://hdl.handle.net/10147/200247
    DOI
    10.1016/j.leukres.2010.01.025
    PubMed ID
    20153526
    Item Type
    Article
    Language
    en
    ISSN
    1873-5835
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.leukres.2010.01.025
    Scopus Count
    Collections
    Cork University Hospital

    entitlement

    Related articles

    • BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria.
    • Authors: Branford S, Seymour JF, Grigg A, Arthur C, Rudzki Z, Lynch K, Hughes T
    • Issue date: 2007 Dec 1
    • Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.
    • Authors: Barbany G, Höglund M, Simonsson B, Swedish CML Group
    • Issue date: 2002 Aug 15
    • Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
    • Authors: Carella AM
    • Issue date: 2007 Mar
    • Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia.
    • Authors: Laneuville P, Dilea C, Yin OQ, Woodman RC, Mestan J, Manley PW
    • Issue date: 2010 Apr 10
    • Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    • Authors: Lahaye T, Riehm B, Berger U, Paschka P, Müller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A
    • Issue date: 2005 Apr 15
    Health Library Ireland | Health Service Executive | Jervis House, Jervis Street | Republic of Ireland | Eircode: D01 W596
    lenus@hse.ie | Tel: +353-1-7786275
    DSpace software copyright © 2002-2017  DuraSpace
    Contact Us | Disclaimer
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.